January 24, 2017 9:28 AM ET

Biotechnology

Company Overview of SkylineDx B.V.

Key Executives for SkylineDx B.V.

NameBoard RelationshipsTitleAge
Dharminder S. Chahal 14 RelationshipsCo-Founder and Chief Executive Officer40
Bob Löwenberg M.D., Ph.D.3 RelationshipsCo-founder and Chief Scientific Officer--
Leonard Kruimer 8 RelationshipsChief Financial Officer58
Leonie de Best No RelationshipsChief Operating Officer--
Peter W. Schineller No RelationshipsChief Commercial Officer55

SkylineDx B.V. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Tom S. Schwarz 22 RelationshipsCavadis B.V.62
John de Koning Ph.D. 41 RelationshipsLife Sciences Partners BV47
Pieter Sonneveld M.D., Ph.D. 12 RelationshipsSkylineDx B.V.65
Christian Schneider DVM, MBA, Ph.D. 18 RelationshipsVesalius Biocapital Partners S.à r.l.51
Jan Hendrik Egberts M.D., Ph.D., MBA 77 RelationshipsOctoPlus N.V.56
View All Board Members

SkylineDx B.V. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
373.5K
Bonus
261.6K
Total Short Term Compensation
469.0K
Total Value of Options
34.2M
Compensation as of Fiscal Year
SkylineDx B.V. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

IsoRay, Inc. Appoints Matthew Branson as Principal Financial Officer and Principal Accounting Officer
January 23, 2017 9:31 PM ET
Four Physicians to Join Cellectis Clinical Advisory Board
January 23, 2017 9:30 PM ET
ImmunoGen, Inc Announce Executive Changes
January 23, 2017 9:26 PM ET
Cascadian Therapeutics, Inc. Announces Resignation of Mark Lampert from the Board of Directors
January 23, 2017 9:02 PM ET
Clal Biotechnology Industries Ltd. Appoints Julian Adams Ph.D. as President and Chief Science Officer
January 23, 2017 5:36 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SkylineDx B.V., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.